Cardiome Pharma (CRME) Misses Q2 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Cardiome Reports Second Quarter 2016 Financial Results
August 9, 2016 4:00 PM EDTCardiome to conduct conference call and webcast today, August 9, 2016 at 4:30pm Eastern (1:30pm Pacific)
NASDAQ: CRMEÂ Â Â Â TSX: COM
VANCOUVER, Aug. 9, 2016 /PRNewswire/ -Â Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today reported financial results for its second quarter ended June 30, 2016. Amounts, unless specified otherwise, are expressed in U.S. dollars and in accordance with generally accepted accounting principles used in the United States of America (U.S. GAAP).
Commenting on Cardiome's Q2, Dr. William Hunter, CEO, said "We believe that the 16% year-over-year... More
Cardiome Announces XYDALBA™ Single Dose Infusion Approval by European Medicines Agency
August 9, 2016 4:00 PM EDTNASDAQ: CRMEÂ Â TSX: COM
VANCOUVER, Aug. 9, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) announced that XYDALBA (dalbavancin) has been approved by the European Medicines Agency (EMA) for administration as a single, 30 minute, 1500mg infusion (three 500mg vials). This single dosing regimen is in addition to the initially approved dosing regimen of 1000 mg (two 500mg vials) followed one week later by 500 mg (a single 500mg vial).
"We are pleased that the EMA has approved the single dose administration of XYDALBA," said Kiran Bhirangi, M.D., Cardiome's... More
